TCG Crossover Management »

Abivax SA F shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $80M 6.1M 13.22
2024-03-31 $16M 1.1M 14.30
2023-12-31 $12M 1.1M 10.70

More positions owned by TCG Crossover Management

Cg Oncology Comm (CGON)
Dyne Therapeutics Comm (DYN)
Abivax SA Adrs (ABVX)
Silence Therapeutics Adrs (SLN)
Cogent Biosciences Comm (COGT)
Savara Comm (SVRA)
Madrigal Pharmaceuticals Comm (MDGL)
Edgewise Therapeutics Comm (EWTX)
Keros Therapeutics Comm (KROS)
Mineralys Therapeutics Comm (MLYS)
Ocular Therapeutix Comm (OCUL)
Tyra Biosciences Comm (TYRA)
Kura Oncology Comm (KURA)
Structure Therapeutics Adrs (GPCR)
Centessa Pharmaceuticals Comm (CNTA)

View all positions for TCG Crossover Management

Top funds holding Abivax SA F

TCG Crossover Management
Deep Track Capital
Dr. Jeffrey R. Jay, M.D.
Cormorant Asset Management
Blackstone Group
Franklin Resources
VR Adviser
Commodore Capital
Henderson Group
Nantahala Capital Management
Samsara BioCapital
Saturn V Capital Management
Morgan Stanley
Silverarc Capital Management
Citadel Advisors

View all funds holding Abivax SA F